What is Solid Biosciences Inc.'s free cash flow margin?

Solid Biosciences Inc. (SLDB) reported free cash flow margin of -1,247.7% in Q4 2022.

How has Solid Biosciences Inc.'s free cash flow margin changed year-over-year?

Solid Biosciences Inc.'s free cash flow margin decreased by 115.0% year-over-year, from -580.4% to -1,247.7%.

What does free cash flow margin mean?

Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.

Solid Biosciences Inc. SLDB Free cash flow margin

Discontinued — last reported Q4 '22

Free cash flow margin at other companies

Sarepta Therapeutics, Inc.SRPT

-28.7%-9.2pp

BiogenBIIB

24.4%-0.4pp

Neurocrine BiosciencesNBIX

26.8%+6.4pp

InsmedINSM

-112.5%-35.3pp

Taysha Gene Therapies, Inc.TSHA

-1,503.6%+621pp

uniQureQURE

-953.7%+169pp

Other financials

Income statement

See full

Revenue$2.0M-40.6%

Operating income-$57.3M-43.1%

Net income-$56.7M-44.4%

EPS (diluted)-$0.52+11.9%

Balance sheet

See full

Cash & equivalents$297.1M+41.1%

Total debt$20.7M-12.5%

Total equity$374.1M+27.1%

Total assets$422.9M+23.0%

Cash flow

See full

Operating cash flow-$47.2M-48.3%

CapEx$165.0K+31.0%

Free cash flow-$47.4M-48.2%

Valuation

See full

Market cap$910.66M+145%

Enterprise value$634.23M+244%

P/S112.5×-10.3×

Profitability

See full

Operating margin-1,315.2%-4,060pp

Net margin-1,062.3%-251,151pp

Returns & leverage

See full

Return on equity-57.4%+2.2pp

Debt / equity0.1×0.0×

Current ratio13.1×+2.2×

Where this comes from

Calculated from Solid Biosciences Inc.’s reported figures.

free cash flow/total revenue=-1,247.7%

Based on trailing twelve months.

The official record: Solid Biosciences Inc.’s 10-K, filed March 13, 2024, on SEC EDGAR. View the filing →

Ask your AI about Solid Biosciences Inc.'s free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Solid Biosciences Inc.'s free cash flow margin?: Solid Biosciences Inc. (SLDB) reported free cash flow margin of -1,247.7% in Q4 2022.
How has Solid Biosciences Inc.'s free cash flow margin changed year-over-year?: Solid Biosciences Inc.'s free cash flow margin decreased by 115.0% year-over-year, from -580.4% to -1,247.7%.
What does free cash flow margin mean?: Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.